Taking diammonium glycyrrhizinate actually increased the enzyme levels.

Diammonium glycyrrhizinate generally refers to diammonium glycyrrhizinate capsules, and enzymes usually refer to transaminases. If transaminase levels rise after taking diammonium glycyrrhizinate capsules, this may be due to inappropriate medication, viral hepatitis, fatty liver, or other reasons. Patients should receive diagnosis and treatment according to the specific cause under medical guidance, which helps the body gradually recover. Detailed analysis is as follows:

1. Inappropriate Medication

Diammonium glycyrrhizinate capsules can treat acute and chronic viral hepatitis. However, if transaminase levels increase after taking the medication, it may be due to inappropriate treatment. It is recommended to discontinue the drug and switch to an alternative treatment under a doctor's supervision.

2. Viral Hepatitis

In patients with hepatitis B, active viral replication can trigger immune responses leading to liver damage. Simply taking glycyrrhizic acid preparations may not adequately control hepatitis, resulting in elevated transaminase levels. Patients should follow medical advice and combine antiviral medications such as sofosbuvir tablets or entecavir capsules for effective treatment.

3. Fatty Liver

Fatty liver is caused by the accumulation of triglycerides within hepatocytes. Using only oral glycyrrhizic acid formulations, which primarily support liver metabolism, is often insufficient for treating fatty liver and may even lead to increased transaminase levels. In such cases, patients should follow medical instructions and combine other medications such as bicyclol tablets or compound bifendate tablets for synergistic therapy.

Besides the above causes, elevated transaminases after taking diammonium glycyrrhizinate capsules may also occur due to autoimmune liver disease, drug allergy, or worsening infections. Patients are advised to seek timely medical attention for proper evaluation and treatment.